PS2-11: Validation of KRAS Mutation Testing Across Five Certified Laboratories

KRAS mutation testing helps oncologists decide whether patients diagnosed with metastatic colorectal cancer (CRC) should be treated with epidermal growth factor receptor (EGFR) inhibitors. These drugs block the EGFR signaling pathway in tumor cells, and thus can slow tumor progression. Mutated KRAS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Feigelson, Heather, Rahm, Alanna Kulchak, Funk, Kellyan, Kauffman, Tia, Johnson, Monique, Richards, Carolyn Sue, LeMarchand, Loic, Goddard, Katrina
Formato: Artigo
Idioma:Inglês
Publicado em: Marshfield Clinic 2011
Assuntos:
SELECTED ABSTRACTS - HMORN 2011: Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3251394/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.2011.1020.ps2-11
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados